nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A brave NEO world: Neoadjuvant osimertinib in resectable EGFR-mutant NSCLC
|
Cortiula, F. |
|
|
181 |
C |
p. |
artikel |
2 |
Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion
|
Pan, Yingying |
|
|
181 |
C |
p. |
artikel |
3 |
Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial
|
Shimokawa, Tsuneo |
|
|
181 |
C |
p. |
artikel |
4 |
Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI’s: Exploration of efficacy of unselected treatment in a multicenter cohort study
|
Steendam, Christi M.J. |
|
|
181 |
C |
p. |
artikel |
5 |
Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC
|
Heenatigala Palliyage, Gayathri |
|
|
181 |
C |
p. |
artikel |
6 |
China lung cancer screening (CLUS) version 2.0 with new techniques implemented: Artificial intelligence, circulating molecular biomarkers and autofluorescence bronchoscopy
|
Zhang, Yanwei |
|
|
181 |
C |
p. |
artikel |
7 |
Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms
|
Ferencz, Bence |
|
|
181 |
C |
p. |
artikel |
8 |
Comparison of electromagnetic navigation bronchoscopy and transthoracic needle biopsy for diagnosing bronchus sign-positive pulmonary lesions
|
Wook Kim, Yeon |
|
|
181 |
C |
p. |
artikel |
9 |
Contents
|
|
|
|
181 |
C |
p. |
artikel |
10 |
Development and validation of a simple general population lung cancer risk model including AHRR-methylation
|
Jacobsen, Katja Kemp |
|
|
181 |
C |
p. |
artikel |
11 |
EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors
|
Shaffer, William |
|
|
181 |
C |
p. |
artikel |
12 |
Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study
|
Tian, Jie |
|
|
181 |
C |
p. |
artikel |
13 |
Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer
|
Alsaddah, Saba |
|
|
181 |
C |
p. |
artikel |
14 |
Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors
|
Tsutsumi, Hirono |
|
|
181 |
C |
p. |
artikel |
15 |
KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma
|
Gallina, F.T. |
|
|
181 |
C |
p. |
artikel |
16 |
Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples
|
Ilié, Marius |
|
|
181 |
C |
p. |
artikel |
17 |
Multimodality therapy for lung cancer invading the chest wall: A study of the French EPITHOR database
|
Tricard, Jérémy |
|
|
181 |
C |
p. |
artikel |
18 |
Neoadjuvant immunotherapy in patients with pulmonary lymphoepithelioma-like carcinoma
|
Hong, Hui-Zhao |
|
|
181 |
C |
p. |
artikel |
19 |
Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study
|
Sänger, Jonathan A. |
|
|
181 |
C |
p. |
artikel |
20 |
Pre-existing tumor host immunity characterization in resected non-small cell lung cancer
|
Rocha, Pedro |
|
|
181 |
C |
p. |
artikel |
21 |
Real-world outcomes in patients with KRAS G12C–mutated advanced non-small cell lung cancer treated with docetaxel in second-line or beyond
|
Gray, Jhanelle E. |
|
|
181 |
C |
p. |
artikel |
22 |
Real-world treatment patterns and survival of patients with ROS1 rearranged stage IV non-squamous NSCLC in the Netherlands
|
ten Berge, Deirdre M.H.J. |
|
|
181 |
C |
p. |
artikel |
23 |
Retraction notice to “Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors” [Lung Cancer 71 (2011) 283–290]
|
Morgillo, Floriana |
|
|
181 |
C |
p. |
artikel |
24 |
Systemic treatment for neuroendocrine non-small cell lung carcinoma: A cases series and a systematic review of the literature
|
Jelli, Blandine |
|
|
181 |
C |
p. |
artikel |
25 |
The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?
|
Pezzuto, Federica |
|
|
181 |
C |
p. |
artikel |